
Intuitive Surgical, Inc. (ISRG)
ISRG Stock Price Chart
Explore Intuitive Surgical, Inc. interactive price chart. Choose custom timeframes to analyze ISRG price movements and trends.
ISRG Company Profile
Discover essential business fundamentals and corporate details for Intuitive Surgical, Inc. (ISRG) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
16 Jun 2000
Employees
15.64K
Website
https://www.intuitive.comCEO
Gary S. Guthart
Description
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
ISRG Financial Timeline
Browse a chronological timeline of Intuitive Surgical, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 20 Apr 2026
Upcoming earnings on 21 Jan 2026
Upcoming earnings on 16 Oct 2025
EPS estimate is $2.00, while revenue estimate is $2.41B.
Earnings released on 22 Jul 2025
EPS came in at $2.19 surpassing the estimated $1.93 by +13.47%, while revenue for the quarter reached $2.44B , beating expectations by +3.77%.
Earnings released on 22 Apr 2025
EPS came in at $1.81 surpassing the estimated $1.74 by +4.02%, while revenue for the quarter reached $2.25B , beating expectations by +3.09%.
Earnings released on 23 Jan 2025
EPS came in at $2.21 surpassing the estimated $1.76 by +25.57%, while revenue for the quarter reached $2.41B , beating expectations by +7.32%.
Earnings released on 17 Oct 2024
EPS came in at $1.84 surpassing the estimated $1.63 by +12.88%, while revenue for the quarter reached $2.04B , beating expectations by +1.63%.
Earnings released on 18 Jul 2024
EPS came in at $1.78 surpassing the estimated $1.54 by +15.58%, while revenue for the quarter reached $2.01B , beating expectations by +1.94%.
Earnings released on 18 Apr 2024
EPS came in at $1.50 surpassing the estimated $1.41 by +6.38%, while revenue for the quarter reached $1.89B , beating expectations by +1.09%.
Earnings released on 23 Jan 2024
EPS came in at $1.60 surpassing the estimated $1.48 by +8.11%, while revenue for the quarter reached $1.93B , beating expectations by +2.11%.
Earnings released on 19 Oct 2023
EPS came in at $1.46 surpassing the estimated $1.41 by +3.55%, while revenue for the quarter reached $1.74B , missing expectations by -1.32%.
Earnings released on 20 Jul 2023
EPS came in at $1.42 surpassing the estimated $1.33 by +6.77%, while revenue for the quarter reached $1.76B , beating expectations by +1.07%.
Earnings released on 18 Apr 2023
EPS came in at $1.23 surpassing the estimated $1.20 by +2.50%, while revenue for the quarter reached $1.70B , beating expectations by +6.30%.
Earnings released on 24 Jan 2023
EPS came in at $1.23 falling short of the estimated $1.26 by -2.38%, while revenue for the quarter reached $1.66B , missing expectations by -0.89%.
Earnings released on 18 Oct 2022
EPS came in at $1.19 surpassing the estimated $1.10 by +8.18%, while revenue for the quarter reached $1.56B , beating expectations by +2.21%.
Earnings released on 21 Jul 2022
EPS came in at $1.14 falling short of the estimated $1.16 by -1.72%, while revenue for the quarter reached $1.52B , missing expectations by -2.46%.
Earnings released on 21 Apr 2022
EPS came in at $1.13 surpassing the estimated $1.08 by +4.63%, while revenue for the quarter reached $1.49B , beating expectations by +4.36%.
Earnings released on 20 Jan 2022
EPS came in at $1.30 surpassing the estimated $1.28 by +1.56%, while revenue for the quarter reached $1.55B , beating expectations by +1.92%.
Earnings released on 19 Oct 2021
EPS came in at $1.19 surpassing the estimated $1.17 by +1.71%, while revenue for the quarter reached $1.40B , beating expectations by +0.79%.
Stock split effective on 5 Oct 2021
Shares were split 3 : 1 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 20 Jul 2021
EPS came in at $1.31 surpassing the estimated $1.02 by +28.43%, while revenue for the quarter reached $1.46B , beating expectations by +5.15%.
Earnings released on 20 Apr 2021
EPS came in at $1.17 surpassing the estimated $0.87 by +34.48%, while revenue for the quarter reached $1.29B , beating expectations by +0.77%.
Earnings released on 21 Jan 2021
EPS came in at $1.19 surpassing the estimated $1.04 by +14.42%, while revenue for the quarter reached $1.33B , beating expectations by +17.33%.
Earnings released on 15 Oct 2020
EPS came in at $0.92 surpassing the estimated $0.69 by +33.33%, while revenue for the quarter reached $1.08B , beating expectations by +60.52%.
ISRG Stock Performance
Access detailed ISRG performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.